The vaccine was being developed to cover every variant of the virus and for delivery by any method. Photo / APThe vaccine was being developed to cover every variant of the virus and for delivery by any method. Photo / APAfter spending $5 million from wealthy investors and receiving close to $1m in government grants, Auckland-based firm Covid-19 Vaccine Corporation (CVC) has shut up shop after failing to secure a further $12m for its first human trial, BusinessDesk reports. The vaccine was being developed to cover every variant of the virus and for delivery by any method. CVC used “bio-bead” technology developed by PolyBatics, a company spun off from Massey University in 2009.

Source: New Zealand Herald May 03, 2023 06:36 UTC